FIELD: pharmacy.
SUBSTANCE: invention is represented by an anhydrous composition for wound treatment, comprising (a) a discontinuous hydrophilic phase containing thermolysin and PEG 400, and (b) a continuous hydrophobic phase containing a hydrophobic base. The discontinuous hydrophilic phase is dispersed in the continuous hydrophobic phase. Composition versions include trypsin, papain, or pepsin.
EFFECT: enhanced enzymatic activity.
8 cl, 9 ex, 13 tbl, 10 dwg
Authors
Dates
2017-05-15—Published
2010-12-08—Filed